Pathway,both,humann2,mpro,num_Ecs,sample
Acarbose and validamycin biosynthesis,2.0,0.0,0.0,14,cow_ec
Aflatoxin biosynthesis,1.0,0.0,0.0,13,cow_ec
"Alanine, aspartate and glutamate metabolism",21.0,2.0,1.0,50,cow_ec
Amino sugar and nucleotide sugar metabolism,27.0,1.0,9.0,119,cow_ec
Aminoacyl-tRNA biosynthesis,22.0,1.0,1.0,31,cow_ec
Aminobenzoate degradation,2.0,1.0,1.0,51,cow_ec
Arachidonic acid metabolism,0.0,1.0,0.0,26,cow_ec
Arginine and proline metabolism,15.0,4.0,8.0,86,cow_ec
Arginine biosynthesis,15.0,2.0,3.0,28,cow_ec
Ascorbate and aldarate metabolism,4.0,2.0,5.0,46,cow_ec
Atrazine degradation,1.0,1.0,0.0,10,cow_ec
Benzoate degradation,4.0,5.0,4.0,69,cow_ec
Biosynthesis of ansamycins,1.0,0.0,0.0,4,cow_ec
Biosynthesis of antibiotics,128.0,17.0,18.0,496,cow_ec
Biosynthesis of secondary metabolites,193.0,24.0,25.0,778,cow_ec
Biosynthesis of siderophore group nonribosomal peptides,1.0,0.0,2.0,6,cow_ec
Biosynthesis of unsaturated fatty acids,2.0,0.0,0.0,16,cow_ec
Biosynthesis of vancomycin group antibiotics,1.0,0.0,0.0,10,cow_ec
Biotin metabolism,11.0,0.0,1.0,20,cow_ec
Butanoate metabolism,12.0,6.0,2.0,55,cow_ec
C5-Branched dibasic acid metabolism,6.0,0.0,0.0,22,cow_ec
Caprolactam degradation,0.0,1.0,2.0,21,cow_ec
Carbapenem biosynthesis,2.0,0.0,0.0,5,cow_ec
Carbon fixation in photosynthetic organisms,16.0,0.0,1.0,25,cow_ec
Carbon fixation pathways in prokaryotes,20.0,1.0,5.0,50,cow_ec
Chloroalkane and chloroalkene degradation,1.0,1.0,1.0,17,cow_ec
Chlorocyclohexane and chlorobenzene degradation,0.0,1.0,2.0,21,cow_ec
Citrate cycle (TCA cycle),15.0,2.0,1.0,26,cow_ec
Cyanoamino acid metabolism,4.0,0.0,1.0,30,cow_ec
Cysteine and methionine metabolism,30.0,5.0,2.0,76,cow_ec
D-Alanine metabolism,3.0,0.0,0.0,6,cow_ec
D-Glutamine and D-glutamate metabolism,4.0,0.0,0.0,12,cow_ec
Dioxin degradation,1.0,0.0,0.0,13,cow_ec
Drug metabolism - cytochrome P450,2.0,0.0,0.0,8,cow_ec
Drug metabolism - other enzymes,13.0,4.0,1.0,25,cow_ec
Ether lipid metabolism,0.0,2.0,0.0,23,cow_ec
Ethylbenzene degradation,1.0,0.0,0.0,6,cow_ec
Fatty acid biosynthesis,8.0,1.0,2.0,17,cow_ec
Fatty acid degradation,4.0,0.0,4.0,29,cow_ec
Fatty acid elongation,1.0,0.0,1.0,13,cow_ec
Flavone and flavonol biosynthesis,0.0,1.0,0.0,32,cow_ec
Fluorobenzoate degradation,0.0,0.0,2.0,14,cow_ec
Folate biosynthesis,16.0,0.0,5.0,51,cow_ec
Fructose and mannose metabolism,19.0,2.0,5.0,75,cow_ec
Galactose metabolism,17.0,2.0,1.0,48,cow_ec
Geraniol degradation,1.0,0.0,1.0,10,cow_ec
Glucosinolate biosynthesis,1.0,0.0,0.0,15,cow_ec
Glutathione metabolism,12.0,1.0,3.0,39,cow_ec
Glycerolipid metabolism,10.0,2.0,4.0,40,cow_ec
Glycerophospholipid metabolism,14.0,4.0,3.0,61,cow_ec
"Glycine, serine and threonine metabolism",21.0,3.0,4.0,68,cow_ec
Glycolysis / Gluconeogenesis,26.0,0.0,4.0,48,cow_ec
Glycosaminoglycan degradation,2.0,1.0,0.0,15,cow_ec
Glycosphingolipid biosynthesis - ganglio series,2.0,0.0,0.0,8,cow_ec
Glycosphingolipid biosynthesis - globo and isoglobo series,2.0,0.0,0.0,13,cow_ec
Glyoxylate and dicarboxylate metabolism,15.0,8.0,4.0,73,cow_ec
Histidine metabolism,14.0,1.0,1.0,38,cow_ec
Human cytomegalovirus infection,1.0,0.0,0.0,2,cow_ec
Human papillomavirus infection,1.0,0.0,0.0,2,cow_ec
Inositol phosphate metabolism,4.0,1.0,3.0,48,cow_ec
Insect hormone biosynthesis,0.0,0.0,1.0,9,cow_ec
Isoquinoline alkaloid biosynthesis,1.0,1.0,0.0,57,cow_ec
Limonene and pinene degradation,0.0,0.0,1.0,16,cow_ec
Linoleic acid metabolism,0.0,1.0,0.0,13,cow_ec
Lipoic acid metabolism,2.0,0.0,0.0,3,cow_ec
Lipopolysaccharide biosynthesis,14.0,0.0,4.0,27,cow_ec
Lysine biosynthesis,15.0,2.0,0.0,28,cow_ec
Lysine degradation,4.0,4.0,4.0,53,cow_ec
Mannose type O-glycan biosynthesis,0.0,1.0,0.0,8,cow_ec
Metabolic pathways,432.0,81.0,89.0,1650,cow_ec
Metabolism of xenobiotics by cytochrome P450,2.0,0.0,0.0,10,cow_ec
Methane metabolism,17.0,2.0,1.0,87,cow_ec
Microbial metabolism in diverse environments,120.0,22.0,34.0,668,cow_ec
Monobactam biosynthesis,5.0,0.0,0.0,10,cow_ec
Mucin type O-glycan biosynthesis,0.0,1.0,0.0,7,cow_ec
N-Glycan biosynthesis,0.0,1.0,0.0,34,cow_ec
Naphthalene degradation,1.0,0.0,0.0,9,cow_ec
"Neomycin, kanamycin and gentamicin biosynthesis",1.0,0.0,0.0,28,cow_ec
Nicotinate and nicotinamide metabolism,10.0,5.0,3.0,59,cow_ec
Nitrogen metabolism,7.0,0.0,2.0,37,cow_ec
Nitrotoluene degradation,1.0,0.0,0.0,7,cow_ec
Novobiocin biosynthesis,3.0,2.0,0.0,16,cow_ec
One carbon pool by folate,13.0,1.0,2.0,24,cow_ec
Other glycan degradation,4.0,1.0,0.0,9,cow_ec
Other types of O-glycan biosynthesis,0.0,1.0,0.0,9,cow_ec
Oxidative phosphorylation,8.0,0.0,0.0,11,cow_ec
PI3K-Akt signaling pathway,1.0,0.0,0.0,2,cow_ec
Pantothenate and CoA biosynthesis,15.0,2.0,0.0,31,cow_ec
Penicillin and cephalosporin biosynthesis,1.0,1.0,0.0,14,cow_ec
Pentose and glucuronate interconversions,14.0,5.0,5.0,67,cow_ec
Pentose phosphate pathway,21.0,1.0,4.0,55,cow_ec
Peptidoglycan biosynthesis,13.0,1.0,0.0,19,cow_ec
Phenazine biosynthesis,1.0,0.0,0.0,13,cow_ec
Phenylalanine metabolism,5.0,2.0,2.0,67,cow_ec
"Phenylalanine, tyrosine and tryptophan biosynthesis",16.0,5.0,0.0,39,cow_ec
Phenylpropanoid biosynthesis,2.0,0.0,0.0,30,cow_ec
Phosphatidylinositol signaling system,3.0,0.0,0.0,29,cow_ec
Phosphonate and phosphinate metabolism,0.0,1.0,2.0,29,cow_ec
Photosynthesis,2.0,0.0,0.0,3,cow_ec
Polyketide sugar unit biosynthesis,4.0,0.0,0.0,27,cow_ec
Porphyrin and chlorophyll metabolism,19.0,7.0,7.0,106,cow_ec
Primary bile acid biosynthesis,0.0,0.0,1.0,19,cow_ec
Propanoate metabolism,17.0,5.0,2.0,55,cow_ec
Purine metabolism,44.0,8.0,6.0,110,cow_ec
Pyrimidine metabolism,31.0,9.0,5.0,65,cow_ec
Pyruvate metabolism,30.0,4.0,5.0,67,cow_ec
Relaxin signaling pathway,1.0,0.0,0.0,1,cow_ec
Retinol metabolism,1.0,0.0,0.0,14,cow_ec
Riboflavin metabolism,5.0,1.0,5.0,28,cow_ec
Selenocompound metabolism,9.0,1.0,0.0,18,cow_ec
Sphingolipid metabolism,3.0,1.0,0.0,27,cow_ec
Starch and sucrose metabolism,20.0,3.0,3.0,76,cow_ec
Streptomycin biosynthesis,8.0,0.0,0.0,18,cow_ec
Styrene degradation,0.0,2.0,1.0,19,cow_ec
Sulfur metabolism,13.0,0.0,1.0,50,cow_ec
Synthesis and degradation of ketone bodies,2.0,0.0,0.0,6,cow_ec
T cell receptor signaling pathway,2.0,0.0,0.0,2,cow_ec
Taurine and hypotaurine metabolism,3.0,1.0,1.0,19,cow_ec
Terpenoid backbone biosynthesis,11.0,4.0,2.0,51,cow_ec
Th1 and Th2 cell differentiation,1.0,0.0,0.0,1,cow_ec
Thermogenesis,1.0,0.0,0.0,1,cow_ec
Thiamine metabolism,9.0,4.0,2.0,26,cow_ec
Toluene degradation,0.0,0.0,3.0,26,cow_ec
"Tropane, piperidine and pyridine alkaloid biosynthesis",3.0,1.0,0.0,27,cow_ec
Tryptophan metabolism,4.0,1.0,4.0,60,cow_ec
Tyrosine metabolism,4.0,2.0,1.0,64,cow_ec
Ubiquinone and other terpenoid-quinone biosynthesis,12.0,2.0,1.0,40,cow_ec
"Valine, leucine and isoleucine biosynthesis",8.0,1.0,0.0,14,cow_ec
"Valine, leucine and isoleucine degradation",7.0,3.0,3.0,36,cow_ec
Various types of N-glycan biosynthesis,1.0,0.0,0.0,23,cow_ec
Vitamin B6 metabolism,8.0,0.0,1.0,26,cow_ec
Xylene degradation,1.0,1.0,0.0,21,cow_ec
Zeatin biosynthesis,1.0,0.0,0.0,10,cow_ec
alpha-Linolenic acid metabolism,2.0,1.0,1.0,12,cow_ec
beta-Alanine metabolism,7.0,2.0,1.0,37,cow_ec
beta-Lactam resistance,1.0,0.0,0.0,1,cow_ec
mTOR signaling pathway,1.0,0.0,0.0,5,cow_ec
